The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling

Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy M. Medina, Xue Yang, Paulina Ramirez, Lois Randolph, Emily Jean Aller, Bindu Santhamma, Manjeet K. Rao, Rajeshwar Rao Tekmal, Hareesh B. Nair, Edward R. Kost, Ratna K. Vadlamudi, Suryavathi Viswanadhapalli

Open source

DOI: 10.3390/ijms242417426
Published: 2023-12-13
Container: International Journal of Molecular Sciences
Publisher: MDPI AG
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ijms242417426,
  title = {The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling},
  author = {Nicole Spencer and Alondra Lee Rodriguez Sanchez and Rahul Gopalam and Panneerdoss Subbarayalu and Daisy M. Medina and Xue Yang and Paulina Ramirez and Lois Randolph and Emily Jean Aller and Bindu Santhamma and Manjeet K. Rao and Rajeshwar Rao Tekmal and Hareesh B. Nair and Edward R. Kost and Ratna K. Vadlamudi and Suryavathi Viswanadhapalli},
  year = {2023},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms242417426},
  url = {https://doi.org/10.3390/ijms242417426}
}

RIS

TY  - JOUR
TI  - The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling
AU  - Nicole Spencer
AU  - Alondra Lee Rodriguez Sanchez
AU  - Rahul Gopalam
AU  - Panneerdoss Subbarayalu
AU  - Daisy M. Medina
AU  - Xue Yang
AU  - Paulina Ramirez
AU  - Lois Randolph
AU  - Emily Jean Aller
AU  - Bindu Santhamma
AU  - Manjeet K. Rao
AU  - Rajeshwar Rao Tekmal
AU  - Hareesh B. Nair
AU  - Edward R. Kost
AU  - Ratna K. Vadlamudi
AU  - Suryavathi Viswanadhapalli
PY  - 2023
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms242417426
UR  - https://doi.org/10.3390/ijms242417426
ER  -

APA

Spencer, N., Sanchez, A. L. R., Gopalam, R., Subbarayalu, P., Medina, D. M., Yang, X., Ramirez, P., Randolph, L., Aller, E. J., Santhamma, B., Rao, M. K., Tekmal, R. R., Nair, H. B., Kost, E. R., Vadlamudi, R. K., & Viswanadhapalli, S. (2023). The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417426

Source records

crossref · retrieved 2026-09-27T10:43:27.220Z